Powered by

-BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update

Aug 06, 2019 - ENP Newswire
Financial Results

NEW YORK - BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today, that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2019, and provide a corporate update, at 8:00 a.m, Eastern Daylight Time, on Tuesday, August 13, 2019.

BrainStorm's President CEO, Chaim Lebovits, will present a corporate ...